抗抗凝血酶(AT)單克隆抗體
Anti-Antithrombin (AT) Monoclonal Antibody
AT3; ATIII; SERPINC1; Anti-Thrombin Antibodies; Serpin Peptidase Inhibitor Clade C Member 1; Coding Sequence Signal Peptide Antithrombin Part 1
- 編號(hào)FAC313Hu02
- 物種Homo sapiens (Human，人) 相同的名稱，不同的物種。
- 效價(jià)C1
- Ig亞型 IgG2b Kappa
- 純化方式蛋白A + 蛋白G親和純化
- 標(biāo)記物無標(biāo)記物
- 激發(fā)波長(zhǎng)
- 單次使用量
- 緩沖液成份磷酸鹽緩沖液（pH7.4,含有0.02% NaN3和50%甘油）
- 性狀液體
- 且適物種-
- 應(yīng)用FCM
- 下載 英文說明書 中文說明書
- 規(guī)格 25test50test 100test 200test 500test
- 價(jià)格 ¥ 720 ¥ 1200 ¥ 1920 ¥ 2400 ¥ 4200
- 欲了解實(shí)際交易價(jià)格和更多情況，請(qǐng)與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
-
產(chǎn)品包裝(模擬)
-
產(chǎn)品包裝(模擬)
-
Human HepG2 cell line was fixed with 2% paraformaldehyde (10 min) , permeabilised with 0.1% BSA-Triton X-100,then stained with 10μg/ml mouse Anti-human AT Monoclonal Antibody (Catalog FAC313Hu02, red histogram) or Isotype control antibody (Catalog IS067-Mu03, green histogram), followed by 1μg/ml FITC-conjugated Anti-mouse IgG Secondary Antibody (Catalog SAA544Mu18).
-
通過ISO 9001、ISO 13485質(zhì)量體系認(rèn)證
用法
For flow cytometry, the suggested use of this reagent is 0.5-2 μg per 10^6 cells in 100 μl volume.
Optimal working dilutions must be determined by end user.
儲(chǔ)存
經(jīng)常使用則4°C保存。-20°C保存不超過一年。避免反復(fù)凍融。
贈(zèng)品
增值服務(wù)
相關(guān)產(chǎn)品
| 編號(hào) | 適用物種：Homo sapiens (Human，人) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| NPC313Hu01 | 抗凝血酶(AT)天然蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| APC313Hu01 | 抗凝血酶(AT)活性蛋白 | Cell?culture;?Activity?Assays. |
| RPC313Hu03 | 抗凝血酶(AT)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| EPC313Hu61 | 抗凝血酶(AT)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPC313Hu01 | 抗凝血酶(AT)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPC313Hu02 | 抗凝血酶(AT)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| APC313Hu61 | 抗凝血酶(AT)活性蛋白 | Cell?culture;?Activity?Assays. |
| PAC313Hu01 | 抗凝血酶(AT)多克隆抗體 | WB; IHC; ICC; IP. |
| PAC313Hu02 | 抗凝血酶(AT)多克隆抗體 | WB; IHC; ICC; IP. |
| PAC313Hu03 | 抗凝血酶(AT)多克隆抗體 | WB; IHC; ICC; IP. |
| LAC313Hu81 | 抗凝血酶(AT)多克隆抗體(異硫氰酸熒光素標(biāo)記) | WB; IHC; ICC; IF. |
| LAC313Hu71 | 抗凝血酶(AT)多克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
| MAC313Hu21 | 抗凝血酶(AT)單克隆抗體 | WB; IHC; ICC; IP. |
| MAC313Hu27 | 抗凝血酶(AT)單克隆抗體 | WB,IHC |
| MAC313Hu29 | 抗凝血酶(AT)單克隆抗體 | WB; IHC; ICC; IP. |
| MAC313Hu23 | 抗凝血酶(AT)單克隆抗體 | WB; IHC; ICC; IP. |
| MAC313Hu24 | 抗凝血酶(AT)單克隆抗體 | WB; IHC; ICC; IP. |
| MAC313Hu26 | 抗凝血酶(AT)單克隆抗體 | WB; IHC; ICC; IP. |
| MAC313Hu22 | 抗凝血酶(AT)單克隆抗體 | WB,IHC |
| MAC313Hu28 | 抗凝血酶(AT)單克隆抗體 | WB; IHC; ICC; IP. |
| MAC313Hu25 | 抗凝血酶(AT)單克隆抗體 | WB; IHC; ICC; IP. |
| FAC313Hu02 | 抗抗凝血酶(AT)單克隆抗體 | FCM |
| FAC313Hu04 | 抗抗凝血酶(AT)單克隆抗體 | FCM |
| FAC313Hu08 | 抗抗凝血酶(AT)單克隆抗體 | FCM |
| LAC313Hu72 | 抗凝血酶(AT)單克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
| LAC313Hu82 | 抗凝血酶(AT)單克隆抗體(異硫氰酸熒光素標(biāo)記) | WB; IHC; ICC; IF. |
| SEC313Hu | 抗凝血酶(AT)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| SCC313Hu | 抗凝血酶(AT)檢測(cè)試劑盒(化學(xué)發(fā)光免疫分析法) | Chemiluminescent immunoassay for Antigen Detection. |
| LMC313Hu | 抗凝血酶(AT)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
| KSC313Hu01 | 抗凝血酶(AT)檢測(cè)試劑盒DIY材料(酶聯(lián)免疫吸附試驗(yàn)法) | Main materials for "Do It (ELISA Kit) Yourself". |
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) |
| Thromb Res | Thalidomide and multiple myeloma serum synergistically induce a hemostatic imbalance in endothelial cells in vitro [PubMed: 25840743] |
| Neurotherapeutics | iTRAQ-Based Quantitative Proteomics Reveals the New Evidence Base for Traumatic Brain Injury Treated with Targeted Temperature Management [pubmed:29247448] |
| Journal of?Clinical?and Aesthetic Dermatology | Detection of Angiotensin II and AT1 Receptor Concentrations in Keloid and Hypertrophic Scar. [] |
| 博士論文 | An Agile Approach to Novel Recombinant Antithrombin Production for use in Biologics Development [] |
留言咨詢
